(Q42164517)

17 October 2017

title

Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin (English)

1 reference

17 October 2017

Hélène Gilson

1

1 reference

17 October 2017

Olivier Schakman

2

1 reference

17 October 2017

Stéphanie Kalista

3

1 reference

17 October 2017

Pascale Lause

4

1 reference

17 October 2017

Kunihiro Tsuchida

5

1 reference

17 October 2017

Jean-Paul Thissen

6

1 reference

17 October 2017

publication date

12 May 2009

1 reference

American Journal of Physiology - Endocrinology and Metabolism

17 October 2017

published in

1 reference

17 October 2017

volume

297

1 reference

17 October 2017

issue

1

1 reference

17 October 2017

page(s)

E157-64

1 reference

Down-regulation of Akt/mammalian target of rapamycin signaling pathway in response to myostatin overexpression in skeletal muscle

17 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Plasmid DNA electrotransfer for intracellular and secreted proteins expression: new methodological developments and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Functional improvement of dystrophic muscle by myostatin blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

The transforming growth factor-beta superfamily of receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Induction of MafBx and Murf ubiquitin ligase mRNAs in rat skeletal muscle after LPS injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Ectopic expression of myostatin induces atrophy of adult skeletal muscle by decreasing muscle gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Gdf11 is a negative regulator of chondrogenesis and myogenesis in the developing chick limb

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Myostatin preferentially down-regulates the expression of fast 2x myosin heavy chain in cattle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Activin A inhibits formation of skeletal muscle during chick development

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Crystal structures of the heparan sulfate-binding domain of follistatin. Insights into ligand binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Myostatin inhibits myoblast differentiation by down-regulating MyoD expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Quadrupling muscle mass in mice by targeting TGF-beta signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Regulation of myostatin activity and muscle growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Opposing effects of activin A and follistatin on developing skeletal muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Myostatin negatively regulates satellite cell activation and self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Redundancy of myostatin and growth/differentiation factor 11 function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Expression of growth/differentiation factor 11, a new member of the BMP/TGFbeta superfamily during mouse embryogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Activin type IIA and IIB receptors mediate Gdf11 signaling in axial vertebral patterning

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Follistatin induction by nitric oxide through cyclic GMP: a tightly regulated signaling pathway that controls myoblast fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Molecular analysis of fiber type-specific expression of murine myostatin promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Role of Akt/GSK-3beta/beta-catenin transduction pathway in the muscle anti-atrophy action of insulin-like growth factor-I in glucocorticoid-treated rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Regulation of myogenic differentiation by androgens: cross talk between androgen receptor/ beta-catenin and follistatin/transforming growth factor-beta signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Expression of the TGF-beta family of ligands is developmentally regulated in skeletal muscle of neonatal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Human follistatin-related protein: a structural homologue of follistatin with nuclear localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Activin-type II receptor B (ACVR2B) and follistatin haplotype associations with muscle mass and strength in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Hypotension in NKCC1 null mice: role of the kidneys

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

Stimulation of skeletal muscle myofibrillar protein synthesis, p70 S6 kinase phosphorylation, and ribosomal protein S6 phosphorylation by inhibition of myostatin in mature mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00193.2009

10.1152/AJPENDO.00193.2009

21 January 2018

Identifiers

DOI

1 reference

17 October 2017

1 reference